<DOC>
	<DOCNO>NCT01316068</DOCNO>
	<brief_summary>Current therapy target albuminuria diabetic nephropathy leave residual urinary albumin secretion , meanwhile leave residual cardiovascular risk . Previous study demonstrate sulodexide could reduce albuminuria type 2 diabetic patient . But data concern Chinese population available . The investigator aim provide evidence effect sulodexide diabetic nephropathy Chinese diabetic patient . Further investigator also test hypothesis sequential administration intravenous oral replacement drug would gain early great reduction albuminuria , compare oral use .</brief_summary>
	<brief_title>Effect Sulodexide Albuminuria Chinese Type 2 Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Albuminuria</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>Diagnosis type 2 diabetes base WHO criteria Age 1875 year old Serum creatinine ≤ 1.5 mg/dL ( 130umol/L ) Albuminuria define urine albumin/creatinine ratio ( ACR ) accord ADA criterion 2009 ( microalbuminuria 30299 ug albumin/mg creatinine macroalbuminuria ≥300 ug albumin/mg creatinine random spot urine collection ) Continued stable seat systolic blood pressure &lt; 180 mmHg diastolic blood pressure &lt; 110 mmHg Willing change antihypertensive medication regimen necessary Willing provide write informed consent participate study Willing take contraception , infertility duration study Type 1 diabetes mellitus Present acute diabetic complication , severe chronic diabetic complication ( e.g . proliferative diabetic retinopathy ) Complicating uncontrolled severe infection Hepatic insufficiency renal insufficiency severe disturbance lipid metabolism Blood pressure ≥ 180/110mmHg Severe concomitant systemic disease ( e.g . cardiac insufficiency , stroke ) , anticipate unable finish trial Uncooperative , unable follow , anticipate unable finish trial Patients know specific renal disease Untreated urinary tract infection would impact urinary protein value Evidence hepatic dysfunction include total bilirubin &gt; 2.0 mg/dL ( 34 mmol/L ) elevate transaminase History Cardiovascular disease follow : Unstable angina pectoris , myocardial infarction , transient ischemic attack , cerebrovascular accident , New York Heart Association Functional Class III IV heart failure , obstructive valvular heart disease hypertrophic cardiomyopathy Any risk bleeding , platelet count &lt; 100×109/L anticipated surgery within research period Active , recurrent metastatic cancer , know HIV infection Participant experimental drug study past 90 day prior enrollment study , plan participate drug study study period Prior exposure sulodexide , either clinical setting participant another clinical study Known allergy intolerance heparinlike compound multiple drug allergy Lactation , pregnancy , anticipate planned pregnancy study period Inability give inform consent cooperate researcher ( e.g . psychiatric disorder ) history noncompliance medical regimen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>diabetic nephropathy</keyword>
	<keyword>albuminuria</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>sulodexide</keyword>
</DOC>